Table 3.
Outcomes at baseline and endline.
| Baseline | Endline | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcomes | Control | Intervention | Control | Intervention | ||||||||
| Primary outcome | N | Frequency | % | N | Frequency | % | N | Frequency | % | N | Frequency | % |
| Compliance with recommended iron and folic acid tablet (IFA) intake on 12+ out of 14 days | 158 | 85 | 53.8% | 155 | 76 | 49.0% | 144 | 106 | 73.6% | 127 | 100 | 78.7% |
| Secondary outcomes | N | Mean | SD | N | Mean | SD | N | Mean | SD | N | Mean | SD |
| Dietary diversity of pregnant women in last 24 h (10 groups) | 158 | 5 | 1.7 | 154 | 4.7 | 1.7 | 144 | 4.7 | 1.5 | 127 | 4.9 | 1.5 |
| Knowledge of iron-rich foods (maximum 9 foods) | 0 | na | 0 | na | 144 | 2.4 | 1.8 | 127 | 3.4 | 1.9 | ||
| ANC visits between baseline and endline | 0 | na | 0 | na | 144 | 1.2 | 0.7 | 127 | 1.2 | 0.7 | ||
| Binary secondary outcomes | N | Frequency | % | N | Frequency | % | N | Frequency | % | N | Frequency | % |
| Consumption of intervention-promoted foods in the last 24 h | 158 | 121 | 76.6% | 154 | 106 | 68.8% | 144 | 79 | 54.9% | 127 | 85 | 66.9% |
| Practicing one or more methods to enhance iron bioavailability in the last 7 days | 158 | 138 | 87.3% | 154 | 135 | 87.7% | 144 | 130 | 90.3% | 127 | 124 | 97.6% |
| Exploratory outcomes | N | Frequency | % | N | Frequency | % | N | Frequency | % | N | Frequency | % |
| Knows > = 1 reason for getting a blood test (out of all those who had a blood test) | 27 | 21 | 78.0% | 22 | 13 | 59.0% | 51 | 34 | 67.0% | 47 | 37 | 79.0% |
| Reasons cited for blood tests | ||||||||||||
| To check for anemia | 27 | 20 | 74.0% | 22 | 13 | 59.0% | 51 | 32 | 63.0% | 47 | 34 | 72.0% |
| To check for blood-borne diseases (HIV, hepatitis) | 27 | 8 | 30.0% | 22 | 4 | 18.0% | 51 | 24 | 47.0% | 47 | 22 | 47.0% |
| To check for syphilis | 27 | 4 | 15.0% | 22 | 3 | 14.0% | 51 | 24 | 47.0% | 47 | 19 | 40.0% |
| To check blood sugar levels | 27 | 7 | 26.0% | 22 | 3 | 14.0% | 51 | 19 | 37.0% | 47 | 18 | 38.0% |
| To see if the blood of the mother and baby are compatible (rhesus factor) | 27 | 2 | 7.0% | 22 | 2 | 9.0% | 51 | 1 | 2.0% | 47 | 4 | 9.0% |
| To conduct thyroid (TSH) tests | 27 | 0 | 0.0% | 22 | 0 | 0.0% | 51 | 4 | 8.0% | 47 | 5 | 11.0% |
| Knowledge of COVID-19: 3 symptoms, 3 precautions, and 1 vulnerable group | 0 | na | 0 | na | 144 | 6 | 4.2% | 127 | 19 | 15.0% | ||
| ANC visits at the right time for her gestational age | 158 | 28 | 17.7% | 154 | 37 | 24.0% | 144 | 44 | 30.6% | 127 | 34 | 26.8% |
ANC, antenatal care; IQR, interquartile range; na, not applicable; SD, standard deviation; TSH, thyroid stimulating hormone.